Market Place
Sourcing Support
Biond Biologics Announces Trial Collaboration With Merck KGaA
29 Oct 2024 //
PR NEWSWIRE
Biond Biologics Doses First Patient With BND-35 In Phase 1 Clinical Trial
24 Jun 2024 //
PR NEWSWIRE
Biond Announces Presentation of BND-35, Anti-ILT3 Antibody at the AACR
26 Mar 2024 //
PR NEWSWIRE
Biond Biologics Announces First Patients Dosed with BND-22 in PI Trial
23 May 2022 //
PRNEWSWIRE
Biond Biologics to Present at the Raymond James LILRB/ILT Symposium
20 Apr 2022 //
PRNEWSWIRE
Biond Biologics Announces Closing of $15 Million Series C Financing
03 Nov 2021 //
PRNEWSWIRE
Biond Biologics Announces First Patient Dosed in Ph1 Clinical Trial of BND-22
26 Apr 2021 //
PRNEWSWIRE
Sanofi, Israel`s Biond Biologics to collaborate on new cancer drug
12 Jan 2021 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.